OM Cannabis Brand Logo

OM

Data Snapshot: Jun 02, 2026
<$50K

May-2026

Sales

Neutral

Trend

6-Month

17

Product Count

SKUs

$18.51

Avg Price

17.6%

YoY Sales Change

2.1%

YoY Price Change

OM is a prominent brand in the medical cannabis industry, known for its persistent efforts to deliver high-quality, FDA-approved medical cannabis backed by ample knowledge and cutting-edge technology. With a decade-long approval from the MOH, OM exhibits a thorough commitment to public health and safety through rigorous standards and secure practices. Engaging advanced technology and gaining insightful knowledge from multiple sources, OM bridges the gap between medical necessity and cannabis use while providing trustworthy health information.
OM Sales

Market Insights Snapshot

OM Historical Sales by Category

OM operated as a single-category brand in May 2026, with Topical accounting for 100.0% of sales and posting 24.88% year-over-year growth alongside an 8.74% month-over-month increase; in the same period, brand-level sales grew 17.56% year over year while average price rose 2.08%. Within Topical, the average price of $18.51 paired with a full-category concentration indicates deeper penetration rather than price-driven lift, and an 8th-place rank in California’s Topical segment situates the brand mid-pack. The pattern implies that OM’s momentum is concentrated in Topical and that incremental share gains are coming from volume expansion more than pricing, positioning the brand to leverage a focused portfolio rather than breadth.

The mix shift toward exclusive focus on Topical, combined with a May 2026 month-over-month gain of 8.74% in that category and an 8th-place rank in California, suggests headroom for rank improvement if current volume trends persist. When paired with a 24.88% Topical year-over-year growth versus a 17.56% total-brand year-over-year lift, the category is outpacing the brand baseline, implying that future positioning hinges on deepening Topical differentiation and distribution rather than diversifying into adjacent categories. The thesis is that OM’s competitive path is to double down on Topical velocity and retail execution to climb from rank 8 while using measured pricing (2.08% year-over-year) to protect unit throughput.

May-2026 Rank
Topical
8
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Topical
100.0%
$18.51
+24.9%
+8.7%
OM

Competitive Landscape

OM sits at #8 in CA Topical for May 2026, up 4 ranks year over year from #12 and edging 1 rank higher versus February 2026’s #9, reaching a peak rank of #8 in May 2026; in contrast, Papa & Barkley held #1 both this year and last despite a -10.9% YoY sales change, while Liquid Flower advanced from #6 to #4 on +62.2% YoY growth, indicating OM’s share gains are rank-driven rather than velocity-led. Meanwhile, Mary's Medicinals stayed at #2 despite a -31.8% YoY decline, and Buddies remained #3 on +33.0% YoY growth, positioning OM’s +4-rank YoY climb alongside a -5.2% to +62.2% competitor spread as a signal that OM is consolidating mid-tier placement through steadier execution rather than outsized volume swings.

OM market ranking for CA Topical

OM

Notable Products

CBD/THC 1:1 Lavender Epsom Bath Salts (25mg CBD, 25mg THC, 6.5oz) posted the standout move in May 2026 with +113.7% month over month and a rank of 2, while Fragrance Free Extra Strength Bath Bomb (1000mg) also surged +60.7% and sits at rank 7. In contrast, CBD/THC 1:1 Rose Geranium Epsom Salt (25mg THC, 25mg CBD, 6.5oz) fell -44.9% to rank 8, and Arnica Relief Bath Bomb (100mg) slipped -9.3% at rank 4, framing a split between aromatherapy variants and functional formats. With four of the top ten as Epsom Salt SKUs and bath bombs occupying ranks 1 and 4, the mix tilts toward therapeutic soak solutions, and the +89.4% lift for CBD/THC 1:4 Love Balm (100mg CBD, 420mg THC, 2oz) at rank 3 signals adjacent topical relief is pulling incremental demand. The pattern implies OM is consolidating around wellness-oriented topicals where higher-potency and 1:1 ratio Epsom Salts convert shoppers, while scent-led variants face cannibalization risk from performance-forward options, even as total category dollars reached 4,677 in one high-velocity SKU.

Product
Category
Jan-2026
Feb-2026
Mar-2026
Apr-2026
May-2026
MoM %
Just Peachy Rosin Bath Bomb (100mg)
Topical
4
2
2
2
1
+10.9%
CBD/THC 1:1 Lavender Epsom Bath Salts (25mg CBD, 25mg THC, 6.5oz)
Topical
3
3
3
7
2
+113.7%
CBD/THC 1:4 Love Balm (100mg CBD, 420mg THC, 2oz)
Topical
8
5
7
7
3
+89.4%
Arnica Relief Bath Bomb (100mg)
Topical
2
1
1
1
4
-9.3%
CBD/THC 1:1 Arnica Pain Relief Epsom Bath Salts (25mg CBD, 25mg THC)
Topical
1
5
5
3
5
+12.5%
CBD/THC 1:1 Recovery Epsom Bath Salts (25mg CBD, 25mg THC, 6.5oz)
Topical
1
4
4
6
6
+36.6%
Fragrance Free Extra Strength Bath Bomb (1000mg)
Topical
10
8
6
9
7
+60.7%
CBD/THC 1:1 Rose Geranium Epsom Salt (25mg THC, 25mg CBD, 6.5oz)
Topical
8
6
9
4
8
-44.9%
CBN/THC 1:5 Lavender Sweet Dreams Rosin Bath Bomb (50mg THC, 10mg CBN, 2.85oz)
Topical
5
7
10
8
9
-23.2%
CBC/THC 1:1 Recovery Epsom Bath Salts (25mg CBC, 25mg THC, 6.5oz)
Topical
>10
>10
>10
>10
10
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market